S-4 Impact 7/10 M&A / Spac

DTSQ Purchaser Inc.

November 16, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Amendment No. 1 to Form S-4 registers up to 57,885,247 Class A shares and 1,931,900 non-redemption warrants of DTSQ Purchaser Inc. (to be renamed PrimeGen Holdings). The proxy/prospectus covers the business combination between DT Cloud Star Acquisition Corp. (DTCS) and PrimeGen US, Inc. (PGUS), signed February 2, 2026 and amended November 10, 2026. Purchase price is $1,489,800,000, with 105,687,444 Pubco shares issued as merger consideration at a $11.05 redemption price.

  • Purchase price for PGUS is $1,489,800,000, less adjustments for PGUS warrants and options.
  • Merger consideration totals 105,687,444 Pubco shares: 19,702,841 Class A and 85,984,603 Class B.
  • Non-redemption warrants: 1,931,900 issued at $2.00 exercise price, exercisable 6-24 months post-closing.
  • Trust account held approximately $18.3 million as of June 10, 2026 after 76.05% of public shares were redeemed.
  • Outside date is January 31, 2027, extendable to April 30, 2027 with shareholder approval.

Price data unavailable.

A $1.49B SPAC merger where 76% of public shares already redeemed, leaving a thin ~$18.3M trust to support the deal.

SPAC business combination with a biotech (SIC 2836) target, following heavy redemptions that shrank the trust to ~$18.3M.

Nasdaq listing approval is a closing condition and cannot be assured; failure would block the combination unless waived. Sponsor compensation and securities issuance may materially dilute non-redeeming public shareholders.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →